Hospital Corporation of China (03869) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal

Bulletin Express

Mar 16

Hospital Corporation of China Limited (stock code: 03869) has notified the market that its Board of Directors will convene on 26 March 2026 in Hong Kong.

The agenda includes:

• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025. • Considering a recommendation on the payment of a final dividend, if any.

The announcement was authorised by Chairman Chen Shuai and dated 16 March 2026. The Board currently comprises three executive directors (Chen Shuai, Pu Chengchuan, Pan Jianli), two non-executive directors (Liu Lu, Wang Nan) and three independent non-executive directors (Dang Jinxue, Shi Luwen, Zhou Xiangliang).

No additional financial figures or dividend details were provided in the filing; these are expected upon the publication of the full FY 2025 results after the 26 March 2026 meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1175773288"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1175773288\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1175773288?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 17:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175773288","market":"us","top_or_hot":-1,"title":"Hospital Corporation of China (03869) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal","media":"Bulletin Express","content":"<p>Hospital Corporation of China Limited (stock code: 03869) has notified the market that its Board of Directors will convene on 26 March 2026 in Hong Kong.</p>\n<p>The agenda includes:</p>\n<p>• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n• Considering a recommendation on the payment of a final dividend, if any.</p>\n<p>The announcement was authorised by Chairman Chen Shuai and dated 16 March 2026. The Board currently comprises three executive directors (Chen Shuai, Pu Chengchuan, Pan Jianli), two non-executive directors (Liu Lu, Wang Nan) and three independent non-executive directors (Dang Jinxue, Shi Luwen, Zhou Xiangliang).</p>\n<p>No additional financial figures or dividend details were provided in the filing; these are expected upon the publication of the full FY 2025 results after the 26 March 2026 meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hospital Corporation of China (03869) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHospital Corporation of China (03869) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-16 17:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hospital Corporation of China Limited (stock code: 03869) has notified the market that its Board of Directors will convene on 26 March 2026 in Hong Kong.</p>\n<p>The agenda includes:</p>\n<p>• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n• Considering a recommendation on the payment of a final dividend, if any.</p>\n<p>The announcement was authorised by Chairman Chen Shuai and dated 16 March 2026. The Board currently comprises three executive directors (Chen Shuai, Pu Chengchuan, Pan Jianli), two non-executive directors (Liu Lu, Wang Nan) and three independent non-executive directors (Dang Jinxue, Shi Luwen, Zhou Xiangliang).</p>\n<p>No additional financial figures or dividend details were provided in the filing; these are expected upon the publication of the full FY 2025 results after the 26 March 2026 meeting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03869","symbol_name":"弘和仁爱医疗","start_time":0,"source_url":"","article_id":"1175773288","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175773288","pubTimestamp":1773653008,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hospital Corporation of China Limited (stock code: 03869) has notified the market that its Board of Directors will convene on 26 March 2026 in Hong Kong. The agenda includes: • Reviewing and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03869":"弘和仁爱医疗"},"translate_title":"中华医院股份有限公司(03869)定于2026年3月26日召开董事会批准2025财年业绩及末期股息建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03869":1},"content_text":"Hospital Corporation of China Limited (stock code: 03869) has notified the market that its Board of Directors will convene on 26 March 2026 in Hong Kong.\nThe agenda includes:\n• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n• Considering a recommendation on the payment of a final dividend, if any.\nThe announcement was authorised by Chairman Chen Shuai and dated 16 March 2026. The Board currently comprises three executive directors (Chen Shuai, Pu Chengchuan, Pan Jianli), two non-executive directors (Liu Lu, Wang Nan) and three independent non-executive directors (Dang Jinxue, Shi Luwen, Zhou Xiangliang).\nNo additional financial figures or dividend details were provided in the filing; these are expected upon the publication of the full FY 2025 results after the 26 March 2026 meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}